13 . 03 .2023
Press release
Galderma delivers strong FY 2022 growth driven by innovation and commercial performance
02 . 03 .2023
Press release
Cetaphil® unveils digital AI skin analysis tool to empower and educate users with sensitive skin
16 . 02 .2023
Press release
Cetaphil raises awareness of the connection between clothing and sensitive skin
06 . 02 .2023
Press release
Galderma Launches Cutting-Edge Formulation With Alastin Skincare® Resurface Skin Polish Developed To Uncover Visibly Glowing Skin
26 . 01 .2023
Press release
Galderma announces the launch of FACE by Galderma™ – a game-changing augmented reality solution helping healthcare professionals grow their activity and improve patient satisfaction
23 . 01 .2023
Press release
Galderma expands footprint with new Global Capability Center in Barcelona to support global growth
20 . 01 .2023
Press release
IMCAS 2023: Galderma to share latest data demonstrating high aesthetic improvement and patient satisfaction across its innovative portfolio
13 . 01 .2023
Press release
"The Full Spectrum of Dermatology: A Diverse And Inclusive Atlas" Launches New, Free Online Image Gallery
09 . 12 .2022
News story
Galderma, the pure-play dermatology category leader and maker of Cetaphil, celebrates grand opening of U.S. headquarters in Dallas
16 . 11 .2022
News story
Sales data confirm Galderma’s range of anti-acne products is the No.1 choice globally